Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism
Clinical trial NCT03266783 · COMPLETED
Trial details
- NCT number
- NCT03266783
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-13
- Primary completion
- 2025-04-30
- Enrollment
- 2760
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.